The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide
range of incurable diseases. Recent rapid advances in biotechnology and molecular …

The COVID-19 pandemic has brought challenges for people with rheumatic disease in
addition to those faced by the general population, including concerns about higher risks of …

Objectives To describe the safety of vaccines against SARS-CoV-2 in people with
inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD). Methods …

Objectives Perform a systematic literature review (SLR) on risk and prognosis of SARS-CoV-
2 infection and vaccination against SARS-CoV-2 in patients with rheumatic and …

As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination
has been considered an effective measure to protect people from the COVID-19 and end the …

Objective To examine the frequency of, and risk factors for, disease flare following COVID-19
vaccination in patients with systemic rheumatic disease (SRD). Methods An international …

Objective Τo report outcomes of breakthrough COVID-19 in comparison with COVID-19 in
unvaccinated patients with systemic rheumatic diseases (SRDs). Methods Patients with SRD …

Objectives To characterize the kinetics of humoral and T-cell responses in rheumatoid
arthritis (RA)-patients followed up to 4-6 weeks (T3) after the SARS-CoV-2 vaccine booster …

The COVID-19 pandemic represents one of the biggest challenges of the 21st century. In
addition to the general effect on society and health-care systems, patients with systemic …

4| CONCLUSIONS In this article, we discuss the probability of ABC-mediated autoimmunity
(flare or new-onset) following COVID-19 vaccination. We find it important to mention here …